On July 7, 2025, BioSig Technologies, Inc. signed a convertible debenture purchase agreement to raise $100 million from Yorkville, with structured conditions for investor conversions and stock issuance. This significant financing includes a $75 million and a $25 million debenture and involves a potential stock sale of up to $1 billion over the next three years.